ESR1 and breast carcinoma: Studies have shown that ER is closely related to the occurrence and development of breast cancer, in which the overexpression of ER α (ER‐positive) accounts for 70% of breast cancer,206 thus being a well‐established target for the treatment of breast cancer.207